Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Skylight Health Group Inc V.SLHG.H

Alternate Symbol(s):  SLHGF

Skylight Health Group Inc. is a Canada-based healthcare services and technology company. The Company operates a Florida-based primary care health network comprised of physical practices providing a range of services from primary care, sub-specialty, allied health and laboratory/diagnostic testing. The Company is focused on helping small and independent practices shift from a traditional fee-for-service (FFS) model to value-based care (VBC) through tools, including proprietary technology, data analytics and infrastructure. The Company has two segments related to its medical services and software and corporate businesses, which also align with the two countries in which it operates, namely, United States and Canada. It provides a range of healthcare services, including primary and urgent care, sub-specialists, allied health and wellness, and laboratory/diagnostic testing.


TSXV:SLHG.H - Post by User

Post by SkywalkerofLukeon Nov 23, 2022 3:17pm
229 Views
Post# 35123026

Q3 Financials

Q3 Financials

Was impressed with SLHG.v SLHGF ‘s Q3 financials.


Some highlights that stuck out to me


- Increased revenue to $20.8 million compared to $16.1 million in the previous quarter (152% growth year over year)

- Net loss from continuing operations reduced by 16% from the previous quarter

- Adjusted EBITDA loss reduced by 27% from the previous quarter to $3.97 million compared to $5.4 million

- + more


Much of the improvements came from continued expansion of the FFS business model and from the growth of the managed care business line including Medicare and Medicare Advantage programs at risk which generated capitated rev. Great looks heading into Q4.


https://skylighthealthgroup.com/2022/11/18/skylight-health-group-reports-third-quarter-2022-financial-results/

<< Previous
Bullboard Posts
Next >>